Angiologix

About:

Angiologix offers cardiovascular diagnostic products used for accurate, non-invasive, and point-of-care testing of endothelial dysfunction.

Description:

As of October 31, 2011, Angiologix, Inc. was acquired by Everist Genomics. Angiologix, Inc., a medical diagnostic device company, provides cardiovascular diagnostic products. Its products are used as tools for accurate, non-invasive, and point-of-care testing of endothelial dysfunction. The company’s diagnostic products are also used in physicians' practices for diagnosing cardiovascular diseases, and for monitoring the effectiveness of cardiovascular therapies. It serves physician-specialists, cardiologists, vascular medicine specialists, endocrinologists, and primary care physicians. Angiologix, Inc. was founded in 2007 and is based in Mountain View, California.